Assessing UCP1 and thermogenic gene products (e.g., MyoD1, LHX8, DIO2, PPARGC1A) in tissue materials removed during elective surgery may be used to predict obesity risk and initiate interventions to mitigate further adipose tissue expansion at an early stage. The gene discussed is LHX8; the disease is obesity disorder.